Investors

This section of the website provides information for existing and potential investors in Vectura Group plc including financial reports, an interactive share price chart and updates on our latest news.

Why invest in us?

Vectura's focused application of technology, know-how and expertise has demonstrated that the potential for new inhaled pharmaceuticals with real therapeutic and commercial value can be realised.

Latest performance

Share price chart

Reports and presentations

Interim Report for six months ended 30 September 2014

Vectura Group plc interim results for the six months ending 30 September 2014

Annual Report and Accounts for Year Ended 31 March 2014

Latest regulatory news

Share price
Upcoming event
12 Jan 2015

J.P. Morgan Annual Healthcare Conference, San Francisco
(Vectura presentation, 14 Jan)